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subjected (range 31.4% in US −38.1% in France, p = 0.827) reported having a NSHE 
at least weekly. Diabetes management was impacted as 20.9% of insulin dependent 
subjects reported decreasing their normal insulin dose on average 18.7 units per day 
over 3.2 days. Further, a mean of 7.0 extra blood glucose tests were conducted in the 
week following their last NSHE. For those whose last NSHE was at work (n = 483), 
work productivity was impacted with 28.6% reported missing work (e.g., leaving 
early) due to this NSHE. For those whose last NSHE occurred during the day but 
outside of work (n = 368), 18.2% of respondents reported work absenteeism due to 
this NSHE. For those whose last NSHE was during sleep (n = 121), 16.5% of respond-
ents reported subsequent work absenteeism. CONCLUSIONS: NSHE’s have a con-
siderable impact on work loss productivity across these countries. The seriousness of 
NSHEs may be underestimated and should be considered an important part of diabetes 
management.
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OBJECTIVES: Weight management and exercise are key self-management treatments 
for patients with type 2 diabetes mellitus (T2DM). This study examined the associa-
tion between trying to lose weight or exercising regularly and health-related quality 
of life among individuals with and without T2DM. METHODS: Respondents to the 
US Study to Help Improve Early evaluation and management of risk factors Leading 
to Diabetes (SHIELD) baseline survey reported if they had tried to lose weight during 
the last 12 months and if they currently exercised regularly for > 6 months. Respond-
ents also completed the SF-12 quality-of-life survey 1 year later. The Physical Com-
ponent Score (PCS) and Mental Component Score (MCS) of the SF-12 were computed, 
and differences between T2DM respondents (n = 2419) and respondents with no 
diabetes mellitus (n = 6750) were tested using t-tests. Linear regression models adjusted 
for age, gender, race, education, household income, body mass index (BMI), and 
diabetes status. RESULTS: Among T2DM respondents, 71% reported trying to lose 
weight in the past 12 months and 20% reported exercising regularly for >6 months, 
compared with 64% of respondents without diabetes reporting trying to lose weight 
and 25% exercising regularly. After adjusting for demographics, BMI and diabetes 
status, trying to lose weight was not associated with higher PCS scores (p = 0.87), but 
was independently associated with higher MCS scores (p = 0.01) in the subsequent 
year. After adjustment, exercising regularly was signiﬁcantly associated with higher 
subsequent PCS and MCS scores (p < 0.001). CONCLUSIONS: Respondents with 
T2DM who reported exercising regularly had signiﬁcantly better physical quality of 
life, compared with respondents without diabetes who exercised regularly. Respond-
ents with T2DM who reported trying to lose weight or exercising regularly for > 6 
months had better mental quality of life, compared with respondents without diabetes 
who tried to lose weight or exercised.
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OBJECTIVES: Hypoglycemia can be a critical issue in T2DM management and may 
impact patients in many ways. Using published data we aimed to identify and evaluate 
the impact of these events on patient quality of life and treatment satisfaction. 
METHODS: A systematic review of literature databases (no date limit, 1066 citations 
retrieved) and conference proceedings (2007–2009) was carried out. Studies reporting 
the effect of hypoglycemic events on quality of life or treatment satisfaction using 
generic or hypoglycemia-speciﬁc measures were included. RESULTS: Seventeen studies 
were identiﬁed that provided useful information for the study question, mostly in 
European populations. All studies relied on self-reporting of hypoglycemic episodes, 
with heterogeneity in methods and classiﬁcation used. Seven of eight studies reported 
negative correlations between reporting (and in three studies also severity) of hypogly-
cemic events and QoL measured using the EQ-5D instrument: the difference between 
patients reporting and not reporting events (summary score: 0.08–0.20 on 0–1 scale; 
VAS: 4.2–11.3 on 0–100 scale) suggests clinical importance. No correlation was 
observed in the sole study examining insulin-treated patients. Four additional studies 
reported correlations between experience of hypoglycemia and lower QoL scores using 
other generic instruments; three studies reported lower scores on the Treatment Sat-
isfaction Questionnaire for Medication in oral antidiabetics (OAD)-treated patients 
experiencing hypoglycemia. The results of three studies indicated that occurrence and 
severity of hypoglycemia were associated with higher Worry scores in the Hypoglyc-
emia Fear Survey-II in OAD-treated patients, with one study further identifying this 
as a clinically important difference when related to treatment satisfaction. CONCLU-
SIONS: This review identiﬁes a body of data which describe the relationship between 
hypoglycemia and patient-reported outcomes. Despite variation in methods and 
instruments used, the results of these studies indicate hypoglycemic events have a 
notable and clinically important impact on quality of life in T2DM patients, including 
those treated with OADs.
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OBJECTIVES: A central Texas HMO plan implemented a pharmacist-led diabetes 
medication management program (MMP) offering co-pay waivers. Medication adher-
ence and diabetic control were compared between patients enrolled in the MMP vs. 
control patients. Health care costs and utilization were also compared. METHODS: 
Patients were enrolled in the MMP if they had baseline A1C levels >7.5% and continu-
ous enrollment throughout the study period (“rolling” enrollment from August 
2006-July 2008). The enrollees and controls were matched 1:1 by age, gender, baseline 
A1C, and Charlson comorbidity index (CCI). A1C and adherence (Medication 
Possession Ratio (MPR)) were measured one year before and after implementation. 
Paired t-tests compared the changes in MPR and A1C. Health care costs and 
utilization were analyzed by year, group, types of service, and diabetes-related vs. 
all-cause claims. RESULTS: A total of 136 patients were enrolled in the MMP for at 
least 1 year (46 of those enrolled for two years). A1C decreased 5% in controls and 
12% in MMP patients; the difference between groups was statistically signiﬁcant (P 
< 0.001). The MPR for oral hypoglycemics increased from 76% to 81% one year after 
in MMP enrollees, whereas MPR remained at 76% in controls; the difference was not 
statistically signiﬁcant (P = 0.159). The baseline health care costs were 23% higher in 
MMP enrollees than controls, possibly due to a few outliers. After one year, the 
average per member per month (PMPM) cost increased by 21% and 14% in MMP 
and control groups, respectively; the larger increase was mainly attributable to growth 
in diabetes-related drug and outpatient claims. Over two years post-implementation, 
the average MMP PMPM increased by 2%, while the average control PMPM 
increased by 14%. CONCLUSIONS: The medication management program improved 
patients’ outcomes. Although one-year costs increased, the slowdown of costs over 2 
years in MMP patients compared to controls indicates potential savings over the long 
term.
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OBJECTIVES: To increase our understanding of the impact of diabetes-related non-
severe hypoglycemic episodes (NSHE’s) on patient functioning and diabetes manage-
ment. METHODS: A web-based survey of adults with diabetes (US, France, Germany, 
and UK). NSHE’s were classiﬁed as occurring in the past month, either during the day 
or during sleep (nocturnal). RESULTS: 6,756 persons with diabetes were surveyed, 
2,430 had at least one NSHE in the past month. The mean age was 46.1 ± 14.8 (range 
18–90), 1378 (56.7%) were female and average duration of diabetes was 12.8 ± 11.8 
years (range 0.08–72.8). 89.2% (n = 2,167) reported at least 1 daytime NSHE and 
44.7% (n = 1086) had at least 1 nocturnal NSHE. In the past month, $45.64 out-of-
pocket was spent on foods, glucose products, transportation, etc. to either prevent or 
cope with these NSHE’s. For daytime NSHE’s, the average amount of time respond-
ents reported not functioning at their usual level was 9.0 ± 24.9 hours if the NSHE 
occurred while they were active and 12.4 ± 62.3 hours for NSHE occurring while not 
active. On average, 8.3 extra blood glucose monitoring test strips were used and 
insulin was decreased on average by 10 units over the following 6 days. For sleep 
related NSHE’s, on average, it took 1.4 ± 1.9 hours to return to sleep with 15.6% 
not being able to go back to sleep at all after the episode. 81.9% (n = 889) reported 
being tired the following day as a result of the event. Sleep related NSHE’s resulted 
in on average 11.4 ± 84.1 extra blood glucose monitoring test strips used and insulin 
was decreased on average by 13.8 units over the following 6 days. CONCLUSIONS: 
NSHE have a considerable impact on daily functioning as well as add to the ﬁnancial 
burden of living with diabetes. The seriousness of NSHE’s may be underestimated and 
should be considered an important part of diabetes management.
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OBJECTIVES: We estimated rates of diabetes care indicated services in adult type 2 
diabetics in a state Medicaid population and associations between receipt of services 
in Fee-For-Service (FFS); Care Management (CM), i.e., fee-for-service plus care coor-
dination; and Managed Care (MC) subprograms. METHODS: A retrospective cohort 
analysis of Indiana Medicaid 2006 and 2007 eligibility, claims, and encounter ﬁles 
was conducted. Persons 18 to 64 y/o, with diabetes based on ICD-9 codes or NDC 
codes, and ≥12 months continuous eligibility in one subprogram were included. Exclu-
